FFPE RNA/DNA Purification Plus Kit
Sequential isolation and purification of total RNA and genomic DNA from FFPE tissue samples
For research use only and NOT intended for in vitro diagnostics.
Formerly Cat. 25000
CE-IVDD marked diagnostic version available here
FFPE RNA/DNA Purification Plus Kit
Sequential isolation and purification of total RNA and genomic DNA from FFPE tissue samples
Register today to receive an exclusive 15% off* on your first order.
Features and Benefits
- Fast and easy processing using rapid spin-column format
- High yields and quality of nucleic acids
- Separate fractionation of RNA and DNA
- Isolate total RNA, from large rRNA down to microRNA (miRNA)
- No phenol or chloroform extractions
- Purified RNA is suitable for a variety of downstream applications, including Small RNA Sequencing. Find out more information on Norgen's NGS services
- Purification is based on spin column chromatography that uses Norgen’s proprietary resin separation matrix
Norgen’s FFPE RNA/DNA Purification Plus Kit provides a rapid method for the sequential isolation and purification of total RNA (including microRNA) and genomic DNA from formalin-fixed paraffin-embedded (FFPE) tissue samples. The RNA and DNA are sequentially purified into separate fractions using this kit. Using formalin to fix tissues leads to crosslinking of the nucleic acids and proteins, and the process of embedding the tissue samples can also lead to fragmentation of the nucleic acids over time. Norgen’s FFPE RNA/DNA Purification Plus Kit provides conditions that allow for the partial reversing of the formalin modifications, resulting in a high quality and yield of nucleic acids. The kit is able to purify all sizes of RNA, from large mRNA and ribosomal RNA down to microRNA (miRNA) and small interfering RNA (siRNA), depending on the age of the FFPE tissue as the degree of fragmentation of the RNA will increase over time. The RNA is purified from other cellular components without the use of phenol or chloroform. The purified RNA is of the highest integrity, and can be used in a number of downstream applications including real time PCR, reverse transcription PCR, Northern blotting, RNase protection and primer extension, and expression array assays. The purified genomic DNA is also of the highest quality, and can be used in PCR reactions, sequencing, Southern blotting and SNP analysis.
Details
Supporting Data
Kit Specifications
|
|
Maximum Binding Capacity
|
Up to 35 μg RNA
Up to 10 μg DNA |
Maximum Column Loading Volume
|
600 μL
|
Size of RNA Purified
|
All sizes, including small RNA (< 200 nt) |
Maximum Amount of Starting Material |
4 sections <20 μM thick
10 mg of unsectioned block |
Storage Conditions and Product Stability
All solutions should be kept tightly sealed and stored at room temperature. The DNAse I and Proteinase K should be stored at -20°C upon arrival. This kit is stable for 1 year after the date of shipment.
Component | Cat. 54300 (50 preps) |
---|---|
Digestion Buffer A | 2 x 25 mL |
Buffer RL | 40 mL |
Enzyme Incubation Buffer A | 6 mL |
Wash Solution A | 2 x 38 mL |
Elution Solution A | 6 mL |
Elution Buffer F | 15 mL |
Proteinase K | 2 x 12 mg |
DNase I | 1 vial |
RNA Purification Micro Columns | 50 |
DNA Purification Micro Columns | 50 |
Collection Tubes | 100 |
Elution Tubes (1.7 mL) | 100 |
Product Insert | 1 |
Documentation
FAQs
Plus
Poor DNA or RNA recovery may be caused by one or more of the following:
- Incomplete lysis of cells or tissue.
Ensure that the appropriate amount of Digestion Buffer A and Proteinase K was used. Increase the incubation time. - Column has become clogged.
Do not exceed the recommended amounts of starting materials. The amount of starting material may need to be decreased if the column shows clogging below the recommended levels. See FAQ related to “Clogged Column” below. - An alternative elution solution was used.
It is recommended that the Elution Solution A and Elution Buffer F supplied with this kit be used for maximum RNA or DNA recovery. - Ethanol or Buffer RL was not added to the lysate.
Ensure that the appropriate amount of ethanol and Buffer RL is added to the lysate before binding to the column. - Ethanol was not added to the Wash Solutions.
Ensure that 90 mL of 96 - 100% ethanol is added to the supplied Wash Solution A prior to use. - Low nucleic acid content in cells or tissues used.
Different tissues and cells have different nucleic acid contents, and thus the expected yield of nucleic acid will vary greatly from these different sources. Please check literature to determine the expected nucleic acid content of your starting material.
Clogged columns may occur due to:
- Insufficient solubilization of cells or tissues.
Ensure that the appropriate amount of Digestion Buffer A with Proteinase K added was used. Increase the incubation time. - Maximum number of sections or amount of tissue exceeds kit specifications.
Refer to specifications to determine if the amount of starting material falls within kit specifications. - Clarified lysate was not used for the binding step.
Ensure that after the lysis step, the sample is centrifuged if significant precipitates are present, and that only the clarified lysate is used in subsequent steps. - Centrifuge temperature is too low.
Ensure that the centrifuge remains at room temperature throughout the procedure. Temperatures below 15°C may cause precipitates to form that can cause the columns to clog.
Eluted RNA can be degraded due to the following factors:
- FFPE sample is old.
The quality of RNA purified may drastically decrease in old samples. For best performance, freshly prepared samples are highly recommended. - RNase contamination.
RNases may be introduced during the use of the kit. Ensure proper procedures are followed when working with RNA. Please refer to “Working with RNA” at the beginning of this user guide. - Too long incubation of lysate at high temperature.
In order to maintain the integrity of the RNA, it is important that the procedure be performed according to the time indicated. This is especially important for the lysate preparation step when the sample is incubated at 55°C and 80°C for 15 minutes each. Incubation beyond the time indicated may lead to fragmentation of RNA. - Improper storage of the purified RNA.
For short term storage, RNA samples may be stored at –20°C for a few days. It is recommended that samples be stored at –70°C for longer term storage. - Prolonged incubation at 55°C.
In order to reverse formalin crosslinks, an incubation at 55°C is required which may lead to degraded RNA.
Nucleic acids may not be performing well in downstream applications due to the following:
- Nucleic acids were not washed 3 times with the provided Wash Solution.
Traces of salt from the binding step may remain in the sample if the column is not washed 3 times with Wash Solution. Salt may interfere with downstream applications, and thus must be washed from the column. - Ethanol carryover.
Ensure that the dry spin under the Column Wash procedure is performed, in order to remove traces of ethanol prior to elution. Ethanol is known to interfere with many downstream applications. - Formalin crosslink was not completely reversed.
Ensure sufficient incubation at 80°C or 90°C is performed to remove formalin crosslink.
The contamination with genomic DNA may be due to the use of large amounts of starting material. To address this issue, it is recommended to perform RNase-free DNase I digestion on the RNA sample after elution to remove genomic DNA contamination.
Citations
Title | Complex Patterns of Genomic Heterogeneity Identified in 42 Tumor Samples and ctDNA of a Pulmonary Atypical Carcinoid Patient |
Citation | Cancer Research Communications 2023. |
Authors | amsin J. Robb ; Peter Tsai ; Sandra Fitzgerald ; Paula Shields ; Pascalene S. Houseman ; Rachna Patel ; Vicky Fan ; Ben Curran ; Rexson Tse ;Jacklyn Ting ; Nicole Kramer ; Braden J. Woodhouse ; Esther Coats ; Polona Le Quesne Stabej; Jane Reeve ; Kate Parker ; Ben Lawrence ; Cherie Blenkiron ; Cristin G. Print |
Title | Fusion transcriptome profiling defines the monoclonal origin of multifocal epithelioid haemangioma of bone |
Citation | Histopathology 2023. |
Authors | Costantino Errani, Ilaria De Benedictis, Alberto Righi, Beatrice Valenti, Elisa Del Savio, Davide Baldazzi, Stefania Benini, Marta Sbaraglia, Brayan Vega Jimenez, Daniel Vanel, Davide Maria Donati, Angelo Paolo Dei Tos, Roberta Maestro |
Title | Molecular Characterization of Patients with Cryptorchidism: Preliminary Search for an Expression Profile Related to That of Testicular Germ-Cell Tumors |
Citation | Diagnostics 2023. |
Authors | García-Andrade, Fabiola, Rosa María Vigueras-Villaseñor, Margarita Dolores Chávez-Saldaña, Julio César Rojas-Castañeda, Ivan Uriel Bahena-Ocampo, Elena Aréchaga-Ocampo, Mauricio Flores-Fortis, José Díaz-Chávez, Luis Alonso Herrera, and Daniel Adrian Landero-Huerta. |
Title | Selection of endogenous control and identification of significant microRNA deregulations in cervical cancer |
Citation | Frontiers in Oncology 2023. |
Authors | T. Stverakova, I. Baranova, P. Mikyskova, B. Gajdosova, H. Vosmikova, J. Laco, V. Palicka and H. Parova |
Title | Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcoma |
Citation | Communications Biology 2023. |
Authors | Jui Wan Loh, Jing Yi Lee, Abner Herbert Lim, Peiyong Guan, Boon Yee Lim, Bavani Kannan, Elizabeth Chun Yong Lee, Ning Xin Gu, Tun Kiat Ko, Cedric Chuan-Young Ng, Jeffrey Chun Tatt Lim, Joe Yeong, Jing Quan Lim, Choon Kiat Ong, Bin Tean Teh & Jason Yongsheng Chan |
Title | Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma |
Citation | british journal of cancer 2023. |
Authors | Laura J. Forker, Becky Bibby, Lingjian Yang, Brian Lane, Joely Irlam, Hitesh Mistry, Mairah Khan, Helen Valentine, James Wylie, Patrick Shenjere, Michael Leahy, Piers Gaunt, Lucinda Billingham, Beatrice M. Seddon, Rob Grimer, Martin Robinson, Ananya Choudhury & Catharine West |
Title | The profiles of miR-4510 expression level in breast cancer |
Citation | Scientific Reports 2023. |
Authors | Sevan Omer Majed & Suhad Asad Mustafa |
Title | The use of whole genome methylation scanning to define genes preferentially suppressed in African American Prostate Cancer |
Citation | Cancer Epidemiology, Biomarkers and Prevention 2017. |
Authors | Rahmatpanah, F., McGuire, K., Lilly, M., McClelland, M., & Mercola, D |
Title | In-Vivo Fusion of Human Cancer and Hamster Stromal Cells Permanently Transduces and Transcribes Human DNA |
Citation | PLoS One 2014. |
Authors | DM Goldenberg, RJ Rooney, M Loo, D Liu, CH Chang |